MPH Health Care AG

MPH Health Care AG is a listed investment holding company headquartered in Berlin, Germany, founded in 2008. It focuses on acquiring, developing, and managing stakes in high-growth healthcare segments, including treatments for chronic diseases such as oncology, HIV/AIDS, neurology, and rheumatology, as well as medical aesthetic services and digitalization in healthcare. The company operates through Beauty, Pharma, and Real Estate segments, with key portfolio holdings like HAEMATO AG for pharmaceuticals and generics in cancer and chronic therapies; M1 Kliniken AG, a leader in aesthetic surgery, plastic treatments, and beauty medicine; and MPH Ventures, investing in cytostatic solutions via Pharmigon GmbH and real estate through CR Capital Real Estate AG. MPH Health Care AG also pursues opportunities in other profitable sectors like residential real estate development in metropolitan areas. Employing a lean team of two and approximately 4.28 million shares outstanding, it emphasizes long-term value creation and supports shareholders through an attractive dividend policy, playing a niche role in channeling capital to innovative healthcare and growth-oriented enterprises across Germany.